University of Michigan: Methodological Limitations Keeping At-Risk Individuals From Accessing Lifesaving HIV Prevention Pill
July 13, 2019
July 13, 2019
ANN ARBOR, Michigan, July 13 [TNSmedicalresearch] -- The University of Michigan issued the following news release:
Methodological limitations in HIV drug implementation studies help to explain why high-risk individuals are not accessing pre-exposure prophylaxis (PrEP) that can reduce the subsequent risk of HIV infection, according to a new University of Michigan study.
Various barriers--from a lack of PrEP training among some doctors to racism in health care--contribute . . .
Methodological limitations in HIV drug implementation studies help to explain why high-risk individuals are not accessing pre-exposure prophylaxis (PrEP) that can reduce the subsequent risk of HIV infection, according to a new University of Michigan study.
Various barriers--from a lack of PrEP training among some doctors to racism in health care--contribute . . .